Watch GRVE. Know when insiders buy.
One email the day a filing lands. Free.
GRVE
GROOVE BOTANICALS INC.
0.00
+0.00 +0.00%
USD · close Sep 16
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
—
not graded: no insider, short or call data yet
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $256KP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$123KNET DEBT $148K52W 0.00 – 0.02SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jun 30 | — | — | — | −$28K | −$21K | — | 0.00 | −$14K | — | — | Aug 11 |
| Q4 2026 · Mar 31derived | — | — | — | −$35K | −$35K | — | -0.01 | −$16K | — | — | Jun 29 |
| Q3 2026 · Dec 31 | — | — | — | −$34K | −$34K | — | 0.00 | −$20K | — | — | Feb 20 |
| Q2 2026 · Sep 30 | — | — | — | −$32K | −$32K | — | 0.00 | −$36K | — | — | Feb 20 |
| Q1 2026 · Jun 30 | — | — | — | −$38K | −$38K | — | 0.00 | −$20K | — | — | Aug 11 |
| Q4 2025 · Mar 31derived | — | — | — | −$31K | −$31K | — | -0.01 | −$18K | — | — | Jun 29 |
| Q3 2025 · Dec 31 | — | — | — | −$33K | −$33K | −339.4% | 0.00 | −$26K | — | — | Feb 20 |
| Q2 2025 · Sep 30 | — | — | — | −$30K | −$30K | — | 0.00 | −$43K | — | — | Feb 20 |
| Q1 2025 · Jun 30 | — | — | — | −$37K | −$37K | — | 0.00 | −$21K | — | — | Feb 20 |
| Q4 2024 · Mar 31derived | — | — | — | −$60K | −$60K | — | -0.01 | −$24K | — | — | Aug 25 |
| Q3 2024 · Dec 31 | — | — | — | −$55K | $14K | — | 0.00 | −$12K | — | — | Feb 25 |
| Q2 2024 · Sep 30 | — | — | — | −$28K | −$30K | — | 0.00 | −$18K | — | — | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Mar 31 | — | — | −$140K | −$140K | — | -0.01 | −$92K | — | — | — | — |
| FY2025 · to Mar 31 | — | — | −$131K | −$131K | — | -0.01 | −$107K | — | — | — | — |
| FY2024 · to Mar 31 | — | — | −$267K | −$202K | — | -0.01 | −$87K | — | — | — | — |
| FY2023 · to Mar 31 | — | — | −$176K | −$121K | — | 0.00 | −$96K | — | — | — | — |
| FY2017 · to Mar 31 | — | — | −$237K | −$243K | — | -0.03 | −$104K | — | — | — | — |
| FY2016 · to Mar 31 | — | — | −$2.8M | −$2.5M | — | -0.15 | −$349K | — | — | — | $0 |
Every number comes from GROOVE BOTANICALS INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.